• Exchange: Sant. Comerc
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:CI

319.210 USD 0.550 0.17%

As of 18:00:04 ET on 07/11/2014.

Snapshot for Biogen Idec Inc (BIIB)

Open: 319.210 Day's Range: 319.210 - 319.210 Volume: 46
Previous Close: 319.760 52wk Range: 221.360 - 351.530 1-Yr Rtn: +44.20%

Stock Chart for BIIB

No chart data available.
  • BIIB:CI 319.210
  • 1D
  • 1M
  • 1Y
319.760
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 27.6804
Relative P/E vs. IPSA -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 11.5320
Est. PEG Ratio 1.3703
Market Cap (M USD) 75,716.55
Shares Outstanding (M) 237.20
30 Day Average Volume 38
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOStephen H Holtzman "Steve"Exec VP:Corporate Development
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil